ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Ultrasound Guided Hyaluronic Injection in Treatment of Trigger Finger

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03131882
Recruitment Status : Recruiting
First Posted : April 27, 2017
Last Update Posted : May 3, 2017
Sponsor:
Information provided by (Responsible Party):
Mahidol University

April 24, 2017
April 27, 2017
May 3, 2017
October 1, 2016
June 30, 2017   (Final data collection date for primary outcome measure)
Success rate [ Time Frame: 1 month, 3 month, 6 months ]
reduction of symptom which needed no further treatment at follow up
Same as current
Complete list of historical versions of study NCT03131882 on ClinicalTrials.gov Archive Site
  • Pain score [ Time Frame: 1 month, 3 month, 6 months ]
    Visual analogue scale changes
  • Functional outcome [ Time Frame: 1 month, 3 months, 6 months ]
    Disability of the arm, shoulder and hand score
  • Pain score [ Time Frame: 1 month, 3 month, 6 months ]
    Visual analogue scale changes
  • Functional outcome [ Time Frame: 1 month, 3 months, 6 months ]
    DASH score
Not Provided
Not Provided
 
Efficacy of Ultrasound Guided Hyaluronic Injection in Treatment of Trigger Finger
Comparing the Efficacy of Ultrasound Guided Hyaluronic Injection With Ultrasound Guided Corticosteroid Injection in Treatment of Trigger Finger
Comparing the Efficacy of Ultrasound Guided Hyaluronic Injection with Ultrasound Guided Corticosteroid Injection in Treatment of Trigger Finger
Randomized controlled trial which designed to compare the success rate, recurrence rate and functional outcomes of patients with trigger finger whom was treated with ultrasound guided hyaluronic acid injection to ultrasound guided corticosteroid injection
Interventional
Phase 2
Phase 3
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Trigger Digit
  • Drug: Hyaluronic Acid
    1 ml of Low molecular weight hyaluronic acid injection under ultrasound guidance after subcutaneous 0.5ml of 1%lidocaine injection
    Other Name: Hyalgan
  • Drug: Triamcinolone Acetonide
    1ml of 10 mg of triamcinolone injection under ultrasound guidance after subcutaneous 0.5 ml 1%lidocaine injection
    Other Name: Shincort inj.
  • Experimental: Hyaluronic acid
    Hyaluronic acid
    Intervention: Drug: Hyaluronic Acid
  • Active Comparator: Triamcinolone acetonide
    10mg/ml Triamcinolone acetonide
    Intervention: Drug: Triamcinolone Acetonide
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
120
Same as current
September 30, 2017
June 30, 2017   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age > 20 years old
  • Quinnell grade I, II, III
  • Acute (< 6 months)

Exclusion Criteria:

  • Quinnell grade IV
  • Diabetes mellitus
  • Rheumatoid arthritis
  • Pregnancy
  • Patient with prior injection or surgery of trigger finger
  • Patient who are allergy to hyaluronic acid
Sexes Eligible for Study: All
20 Years and older   (Adult, Older Adult)
No
Contact: Picharn Pchyangkul, M.D. +6685-1197710 ppicharn@hotmail.com
Contact: Thepparat Kanchanathepsak, M.D. +662-2011589
Thailand
 
 
NCT03131882
05-58-04
No
Studies a U.S. FDA-regulated Drug Product: Yes
Studies a U.S. FDA-regulated Device Product: No
Product Manufactured in and Exported from the U.S.: Yes
Plan to Share IPD: No
Mahidol University
Mahidol University
Not Provided
Principal Investigator: Thepparat Kanchanathepsak, M.D. Faculty of medicine Ramathibodi hospital, Mahidol university
Mahidol University
May 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP